Gedeon Richter and Forest Laboratories Announce Collaboration Agreement on Atypical Antipsychotic for Schizophrenia, Bipolar Mania and Other Psychiatric Disorders
Gedeon Richter Limited and its wholly owned subsidiary Gedeon Richter USA, Inc. and Forest Laboratories Ireland, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. have entered into a collaboration agreement for Richter's atypical antipsychotic RGH-188 and related compounds.
Source: biz.yahoo.com
Click here for the full story!
23.11.2004